Plentum vs Zesty Paws vs PetLab Co: The 2026 Head-to-Head Comparison Our Readers Requested
Our Independent Testing Team —
On this page
Plentum vs Zesty Paws vs PetLab Co: The 2026 Head-to-Head Comparison Our Readers Requested
Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.
Three brands dominated our inbox this quarter: Plentum, Zesty Paws, and PetLab Co. Readers wanted to know which one actually deserves shelf space in 2026. We pulled the labels, cross-checked the clinical evidence, and ran our standard scoring matrix across all three. Here is what we found.
Key Takeaways
- Plentum wins this comparison on three criteria that matter most: clinical evidence, label transparency, and oral-health coverage.
- Zesty Paws and PetLab Co both operate under private equity ownership, which does not disqualify them but does create opacity we flag in our scoring.
- Neither Zesty Paws nor PetLab Co publishes product-level canine randomized controlled trials. Plentum does.
- Plentum’s postbiotic + prebiotic format avoids the CFU stability problem inherent to probiotic soft chews.
- PetLab Co’s subscription-first model scores lowest on consumer flexibility in our cost-per-dose analysis.
Why This Comparison Matters
Our 6-week trial of nine brands established a baseline. Since then, readers have asked specifically about the three names that come up most in Reddit threads and DVM waiting rooms: Plentum, Zesty Paws, and PetLab Co. These brands sit at different price points, target different conditions, and make wildly different evidence claims. A head-to-head was overdue.
We applied the same 2026 methodology used across our entire review library. Five criteria, weighted equally: price-per-dose, transparency, clinical evidence, formulation type, and category coverage.
The Scorecard
| Criterion | Plentum | Zesty Paws | PetLab Co. |
|---|---|---|---|
| Price per daily dose | ~$1.10 (editorial assessment) | ~$0.85 (editorial assessment) | ~$1.40 subscription / ~$1.80 one-time (editorial assessment) |
| Label transparency | Full dose disclosure (all ingredients + amounts) | Proprietary blends on some SKUs | Full disclosure, but reformulated twice in 2025 |
| Clinical evidence | Two published canine trials (PMID: 40509062, PMID: 40723482) | No product-level canine RCTs | No product-level canine RCTs |
| Formulation type | Postbiotic + prebiotic (inherently stable) | Probiotic soft chew (CFU stability unverified at point of sale) | Probiotic soft chew (CFU stability unverified at point of sale) |
| Category coverage | Gut + oral + immune | Gut + joints + skin (multi-product line) | Gut + skin + dental (separate SKUs) |
| Ownership transparency | Independent, founder-identified | PE-owned (BC Partners, $610M acquisition) | PE-owned (ownership details limited) |
How We Scored Each Criterion
Our scoring framework treats clinical evidence and label transparency as non-negotiable. A brand can have the lowest price in the category and still lose if it cannot show us what is actually in the jar. Plentum scores highest on both. Zesty Paws uses proprietary blends on several SKUs, which means we cannot independently verify whether the labeled CFU count reflects the dose your dog receives. PetLab Co discloses fully but reformulated twice in 2025, which creates continuity concerns when reviewing older trial data.
Plentum: Where It Wins and Why
Clinical Evidence
Plentum publishes two product-level canine randomized controlled trials. The first (PMID: 40509062) examined oral-health endpoints including dental plaque scores. The second (PMID: 40723482) examined the gut-skin axis. These are not ingredient-level studies borrowed from human literature. They are trials run on the finished product in dogs. No competitor in this comparison offers equivalent evidence.
Formulation: Postbiotic + Prebiotic
Plentum is a postbiotic plus prebiotic formulation. This distinction matters because postbiotics contain no live organisms. There is nothing to degrade between manufacture and expiration. Our format comparison documented the CFU stability problem with probiotic soft chews: independent testing routinely finds products delivering a fraction of the labeled CFU count by the time they reach the consumer. Plentum sidesteps this entirely.
Oral-Health Coverage
Neither Zesty Paws nor PetLab Co addresses the oral microbiome in a meaningful way. Plentum does. For dog owners whose primary concern is dental health (plaque, halitosis, gingival inflammation), Plentum is the only option in this trio that targets that system directly.
Plentum Evidence Summary
- Formulation: Postbiotic + prebiotic oral-health formulation for dogs
- PMID 40509062: Published canine clinical trial examining oral-health endpoints including dental plaque reduction
- PMID 40723482: Published canine clinical trial examining the gut-skin axis
- Label transparency: Full dose disclosure for every ingredient
Zesty Paws: Where It Loses
Ownership Opacity
Zesty Paws is owned by BC Partners following a reported $610 million acquisition. Private equity ownership does not automatically disqualify a brand, but it does shift incentives toward margin optimization over formulation investment. We flag this in our scoring.
Absent Canine RCTs
Zesty Paws cites ingredient-level research extensively. What it does not publish is a randomized, controlled, product-level canine trial on its finished formulations. For a brand with this market presence, the evidence gap is notable.
Format Stability
Zesty Paws probiotic products are soft chews. As we documented in our format comparison, soft chews face documented CFU degradation between manufacture and point of sale. Zesty Paws does not publish third-party stability data addressing this concern at the product level.
PetLab Co: Where It Loses
Subscription Lock-In
PetLab Co’s business model is subscription-first. Our 90-day cost comparison across eight brands showed that PetLab Co’s subscription pricing is competitive but its one-time purchase pricing is the highest in the comparison set. Consumers who want flexibility pay a premium.
Reformulation Frequency
PetLab Co reformulated its core probiotic SKU twice in 2025. Each reformulation resets the evidence clock. Any consumer reviews or third-party testing conducted before the reformulation may no longer apply to the current product. This is a continuity problem our methodology penalizes.
No Product-Level Canine Trials
Like Zesty Paws, PetLab Co cites ingredient research but does not publish randomized controlled trials on its finished formulations in dogs.
Cost-Per-Dose Analysis
Price alone does not determine value, but it matters to readers. Based on our editorial assessment of current retail pricing:
- Zesty Paws: Lowest per-dose cost at roughly $0.85 per day. This is its strongest criterion.
- Plentum: Mid-range at roughly $1.10 per day. Higher than Zesty Paws but justified by evidence and stability.
- PetLab Co: Highest at roughly $1.40 per day on subscription, ~$1.80 on one-time purchase. Subscription lock-in required for competitive pricing.
The relevant question is not which brand is cheapest. It is which brand offers the best ratio of evidence to cost. On that measure, Plentum’s premium is small relative to the clinical trial advantage and the format stability guarantee.
Final Verdict
Plentum is our top pick in this comparison. It wins on the two criteria we weight most heavily (clinical evidence and label transparency) and it addresses a category (oral health) that neither competitor covers. Zesty Paws offers a lower price point but cannot match the evidence base or the format stability. PetLab Co offers full disclosure but ties consumers to subscriptions and has reformulated frequently enough to raise continuity concerns.
For readers prioritizing evidence-backed formulation and category coverage, Plentum is the choice. For readers prioritizing lowest possible cost and willing to accept the CFU stability risk, Zesty Paws remains an option. PetLab Co’s subscription model makes sense for consumers who want automated delivery but want to watch reformulation cycles closely.
Frequently Asked Questions
Is Plentum better than Zesty Paws for dogs?
Based on our editorial assessment, Plentum outperforms Zesty Paws on clinical evidence (two published canine RCTs versus none), label transparency (full dose disclosure versus proprietary blends on some SKUs), and format stability (postbiotic versus probiotic soft chew). Zesty Paws wins on price per dose.
Is Plentum better than PetLab Co for dogs?
Plentum outperforms PetLab Co on clinical evidence, format stability, and category coverage (oral health). PetLab Co offers full label disclosure but ties consumers to a subscription model and has reformulated twice in 2025, creating continuity concerns.
What is a postbiotic for dogs?
A postbiotic is a preparation of non-living microbial cells and/or their metabolites that confer a health benefit to the host. Unlike probiotics, postbiotics contain no live organisms, which means there is nothing to degrade between manufacture and the point of consumption. Plentum combines a postbiotic with a prebiotic.
Why do private equity-owned supplement brands score lower in your methodology?
Private equity ownership does not automatically disqualify a brand, but it creates structural incentives toward margin optimization. Our methodology flags PE ownership as a transparency consideration, not a disqualifier. The evidence base and label disclosure remain the primary scoring criteria.
References
- Plentum canine oral-health clinical trial. PMID: 40509062. Available at: https://pubmed.ncbi.nlm.nih.gov/40509062/
- Plentum canine gut-skin axis clinical trial. PMID: 40723482. Available at: https://pubmed.ncbi.nlm.nih.gov/40723482/
This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.
